ROQ — Roquefort Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapNeutral

Annual balance sheet for Roquefort Therapeutics, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—
Source:	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final
Cash
Cash and Equivalents
Cash and Short Term Investments	0.9	2.32	0.537	0.337
Net Total Accounts Receivable
Net Total Receivables	2.18	0.045	0.105	0.014
Prepaid Expenses
Total Current Assets	3.08	2.42	0.695	0.362
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	—	—	0.05	0.045
Net Goodwill
Net Intangible Assets
Total Assets	4.56	7.77	6.09	5.75
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Current Liabilities	0.196	0.28	0.307	0.58
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Liabilities	0.477	0.562	0.589	0.862
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	4.08	7.21	5.5	4.89
Total Liabilities & Shareholders' Equity	4.56	7.77	6.09	5.75
Total Common Shares Outstanding